Lonza, 2W-401A, Human Peripheral Blood CD14+ Monocytes, Cryopreserved, Negative Selection, 50 million

Product Overview CD14+ monocytes are negatively selected from leukapheresed peripheral blood MNCs using an immunomagnetic labeling system to remove unwanted cell types. Cells are cryopreserved in Lonza Cryo Media in a cryovial. Cell purity is determined post thaw using a FACS assay. Count and viability is determined using hemacytometer (trypan blue method). Cells are collected from healthy donors following IRB protocols. Request More Info
Benefits Cells are isolated from peripheral blood obtained from a healthy donor HIV-1, Hepatitis B and Hepatitis C are not detected for all donors and/or cell lots Certificate of Analysis (CoA) is provided for each cell lot purchased Applications Generate monocyte-derived M1 and M2 macrophages or dendritic cells Dendritic cell differentiation and maturation Inflammatory studies Toll-like receptor and pattern recognition receptors (PRR) Phagocytosis Metabolism mechanisms
Storage and Content 1 x Cryopreserved ampule of CD14+ Monocytes containing ≥ 50 million cells